Literature DB >> 9195540

Quality of life measurement in osteoporosis.

S L Silverman1, A Cranney.   

Abstract

Quality of life measurement may be helpful in randomized clinical trials in osteoporosis to assess therapeutic tradeoffs and compare effects of different interventions. Quality of life measures include generic measures, disease targeted measures, and performance based measures. Disease targeted measures increase the coverage of domains that are of particular importance to the patient with established osteoporosis. Several disease targeted measures are currently available. These measures show discriminant validity, but data on longitudinal responsiveness and validity in randomized clinical trials are not yet available.

Entities:  

Mesh：

Year:  1997        PMID： 9195540

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  10 in total

1.  Determinants of health-related quality of life in women with vertebral fractures.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; George Ioannidis; Jacques P Brown; Anjali Pathak; David A Hanley; Robert G Josse; Rolf J Sebaldt; Wojciech P Olszynski; Alan Tenenhouse; Timothy M Murray; Annie Petrie; Charles H Goldsmith; Jonathan D Adachi
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

2.  Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial.

Authors:  S Silverman; H N Viswanathan; Y-C Yang; A Wang; S Boonen; S Ragi-Eis; P Fardellone; N Gilchrist; P Lips; M Nevitt; S Palacios Gil-Antuñano; K Pavelka; D Revicki; J Simon; D Macarios; E S Siris
Journal:  Osteoporos Int       Date:  2011-07-19       Impact factor: 4.507

3.  A model of health education and management for osteoporosis prevention.

Authors:  Liang Wang; Xiaowen Xu; Yan Zhang; Hongxia Hao; Liying Chen; Tianjiao Su; Yan Zhang; Weifeng Ma; Yuanyuan Xie; Tiantian Wang; Fan Yang; Li He; Wenjiao Wang; Xuemei Fu; Yuanzheng Ma
Journal:  Exp Ther Med       Date:  2016-10-19       Impact factor: 2.447

4.  Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial.

Authors:  J D Adachi; K W Lyles; C S Colón-Emeric; S Boonen; C F Pieper; C Mautalen; L Hyldstrup; C Recknor; L Nordsletten; K A Moore; C Bucci-Rechtweg; G Su; E F Eriksen; J S Magaziner
Journal:  Osteoporos Int       Date:  2011-01-20       Impact factor: 4.507

Review 5.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

6.  Effectiveness of teriparatide treatment on back pain-related functional limitations in individuals affected by severe osteoporosis: a prospective pilot study.

Authors:  Giovanni Iolascon; Francesca Gimigliano; Nazzarena Malavolta; Umberto Tarantino; Rachele Fornari; Emanuela Greco; Gioconda Di Pietro; Raffaele Gimigliano; Andrea Lenzi; Giuseppina Resmini; Silvia Migliaccio
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

7.  The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  J D Adachi; G Ioannidis; L Pickard; C Berger; J C Prior; L Joseph; D A Hanley; W P Olszynski; T M Murray; T Anastassiades; W Hopman; J P Brown; S Kirkland; C Joyce; A Papaioannou; S Poliquin; A Tenenhouse; E A Papadimitropoulos
Journal:  Osteoporos Int       Date:  2003-08-12       Impact factor: 4.507

Review 8.  Quality of life measurements in patients with osteoporosis and fractures.

Authors:  Melisa M Madureira; Rozana M Ciconelli; Rosa M R Pereira
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

9.  INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty.

Authors:  Leigh A Gray; Jeffrey G Jarvik; Patrick J Heagerty; William Hollingworth; Lydia Stout; Bryan A Comstock; Judith A Turner; David F Kallmes
Journal:  BMC Musculoskelet Disord       Date:  2007-12-20       Impact factor: 2.362

10.  Health-related Quality of Life in Accordance with Fracture History and Comorbidities in Korean Patients with Osteoporosis.

Authors:  Hye-Young Kwon; Yong-Chan Ha; Jun-Il Yoo
Journal:  J Bone Metab       Date:  2016-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.